赛伦生物:2025年度业绩快报公告

Group 1 - The company, Sairun Bio, announced that it expects to achieve total operating revenue of 196.21 million yuan in 2025, representing a year-on-year growth of 0.66% [2] - The net profit attributable to the parent company is projected to be 51.71 million yuan, reflecting a year-on-year increase of 16.76% [2]

Shanghai Serum Bio-Technology -赛伦生物:2025年度业绩快报公告 - Reportify